Evidence map›Paper›PMID 26791145›Full record

ArticleIntensive care medicine experimental2016

Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster.

Ata Murat Kaynar, Veli Bakalov, Silvia Martinez Laverde, Amélie I F Cambriel, Byoung-Hoon Lee, Atif Towheed, Alyssa D Gregory, Steven A R Webb, Michael J Palladino, Fernando A Bozza and 2 more

Abstract read
In one paragraph

Article in Intensive care medicine experimental, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The "yeast-drop" treatment protocol in theFrontiers in tuberculosis · 2026
    Article
  2. Article
  3. Frontiers in microbiology · 2024
    Review
  4. Prolonged Transcriptional Consequences in Survivors of Sepsis.International journal of molecular sciences · 2021
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ata Murat KaynarClinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, 612 Scaife Hall, 3550 Terrace Street, Pittsburgh, 15261, PA, USA. kaynarm@upmc.edu.
Veli BakalovClinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, 612 Scaife Hall, 3550 Terrace Street, Pittsburgh, 15261, PA, USA.
Silvia Martinez LaverdeDepartment of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
Amélie I F CambrielUniversité Paris Descartes, 75270, Paris, Cedex 06, France.
Byoung-Hoon LeeDepartment of Pulmonology and Allergy, Eulji University, Seoul, 139-711, Korea.
Atif TowheedDepartment of Pharmacology and Chemical Biology, Pittsburgh, PA, 15260, USA.
Alyssa D GregoryDepartment of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
Steven A R WebbSchool of Population Health, University of Western Australia, Crawly, Perth, WA, 6009, Australia.
Michael J PalladinoDepartment of Pharmacology and Chemical Biology, Pittsburgh, PA, 15260, USA.
Fernando A BozzaInstituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, 21040-360, Brazil.
Steven D ShapiroDepartment of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
Derek C AngusClinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, 612 Scaife Hall, 3550 Terrace Street, Pittsburgh, 15261, PA, USA.

Funding

Combined viral and bacterial infection and zinc homeostasis in distal lungR01HL126711 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAYNAR, A. MURAT · 2015 to 2019
$2.0M
Neutrophil Collagenase in Sepsis and Ventilator Induced Lung InjuryK08HL086671 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAYNAR, A. MURAT · 2009 to 2013
$603k
NHLBI NIH HHS K08 HL086671NHLBI NIH HHS R01 HL126711
6 · The paper itself

Abstract

backgroundMultiple organ failure, wasting, increased morbidity, and mortality following acute illness complicates the health span of patients surviving sepsis. Persistent inflammation has been implicated, and it is proposed that insulin signaling contributes to persistent inflammatory signaling during the recovery phase after sepsis. However, mechanisms are unknown and suitable pre-clinical models are lacking. We therefore developed a novel Drosophila melanogaster model of sepsis to recapitulate the clinical course of sepsis, explored inflammation over time, and its relation to impaired mobility, metabolic disturbance, and changes in lifespan.

methodsWe used wild-type (WT), Drosomycin-green fluorescent protein (GFP), and NF-κB-luc reporter male Drosophila melanogaster 4-5 days of age (unmanipulated). We infected Drosophila with Staphylococcus aureus (infected without treatment) or pricked with aseptic needles (sham). Subsets of insects were treated with oral linezolid after the infection (infected with antibiotics). We assessed rapid iterative negative geotaxis (RING) in all the groups as a surrogate for neuromuscular functional outcome up to 96 h following infection. We harvested the flies over the 7-day course to evaluate bacterial burden, inflammatory and metabolic pathway gene expression patterns, NF-κB translation, and metabolic reserve. We also followed the lifespan of the flies.

resultsOur results showed that when treated with antibiotics, flies had improved survival compared to infected without treatment flies in the early phase of sepsis up to 1 week (81 %, p = 0.001). However, the lifespan of infected with antibiotics flies was significantly shorter than that of sham controls (p = 0.001). Among infected with antibiotic sepsis survivors, we observed persistent elevation of NF-κB in the absence of any obvious infection as shown by culturing flies surviving sepsis. In the same group, geotaxis had an early (18 h) and sustained decline compared to its baseline. Geotaxis in infected with antibiotics sepsis survivors was significantly lower than that in sham and age-matched unmanipulated flies at 18 and 48 h. Expression of antimicrobial peptides (AMP) remained significantly elevated over the course of 7 days after sepsis, especially drosomycin (5.7-fold, p = 0.0145) on day 7 compared to that of sham flies. Infected with antibiotics flies had a trend towards decreased Akt activation, yet their glucose stores were significantly lower than those of sham flies (p = 0.001). Sepsis survivors had increased lactate levels and LDH activity by 1 week, whereas ATP and pyruvate content was similar to that of the sham group.

conclusionsIn summary, our model mimics human survivors of sepsis with persistent inflammation, impaired motility, dysregulated glucose metabolism, and shortened lifespan.

Indexed as

AktDrosomycinDrosophilaInsulinRecoverySepsis

Identifiers

PMID26791145
PMCPMC4720623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.